Afeyan Noubar

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

+19.1%

median move per position

+8.8%

S&P 500 median, same spans

1 of 1

beat the S&P ~6mo later

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$75.00M bought · −$1.14M sold

All filings on record

Every Form 4 transaction we track for this filer

All10Buys3Sells1

Stock	Transaction	Date	~6mo vs S&P
MRNAModerna, Inc.	Sell $433.9K · 9,263 sh	2026-05-21	—
MRNAModerna, Inc.	Exercise $177.4K · 9,263 sh	2026-05-21	—
GENBGenerate Biomedicines, Inc.	Convert — · 2,777,752 sh	2026-03-02	—
GENBGenerate Biomedicines, Inc.	Convert — · 2,777,752 sh	2026-03-02	—
GENBGenerate Biomedicines, Inc.	Convert — · 987,491 sh	2026-03-02	—
GENBGenerate Biomedicines, Inc.	Convert — · 13,702,224 sh	2026-03-02	—
GENBGenerate Biomedicines, Inc.	Convert — · 12,723,940 sh	2026-03-02	—
GENBGenerate Biomedicines, Inc.	Buy $25.00M · 1,562,500 sh	2026-03-02	—
GENBGenerate Biomedicines, Inc.	Buy $25.00M · 1,562,500 sh	2026-03-02	—
GENBGenerate Biomedicines, Inc.	Buy $25.00M · 1,562,500 sh	2026-03-02	—

MRNASell

2026-05-21 · Moderna, Inc.

$433.9K

—

MRNAExercise

2026-05-21 · Moderna, Inc.

$177.4K

—

GENBConvert

2026-03-02 · Generate Biomedicines, Inc.

2,777,752

—

GENBConvert

2026-03-02 · Generate Biomedicines, Inc.

2,777,752

—

GENBConvert

2026-03-02 · Generate Biomedicines, Inc.

987,491

—

GENBConvert

2026-03-02 · Generate Biomedicines, Inc.

13,702,224

—

GENBConvert

2026-03-02 · Generate Biomedicines, Inc.

12,723,940

—

GENBBuy

2026-03-02 · Generate Biomedicines, Inc.

$25.00M

—

GENBBuy

2026-03-02 · Generate Biomedicines, Inc.

$25.00M

—

GENBBuy

2026-03-02 · Generate Biomedicines, Inc.

$25.00M

—

Newest 10 of 17 filings·Every Form 4 on record, with outcomesPro →

Filing in the same companies

Other insiders active in these names in the last 3 years

BS

Bancel Stephane

GENB · MRNA · last 2026-03-02

KS

Klinger Shannon Thyme

MRNA · last 2026-09-04

MJ

Mock James M

MRNA · last 2026-09-04

HS

Hoge Stephen

MRNA · last 2026-08-28

GB

Grous Beth

GENB · last 2026-03-02

MJ

Mendillo Jane L

GENB · last 2026-03-02

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.